These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19767771)

  • 1. Transcription activity is required for p53-dependent tumor suppression.
    Gaidarenko O; Xu Y
    Oncogene; 2009 Dec; 28(49):4397-401. PubMed ID: 19767771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.
    Song H; Hollstein M; Xu Y
    Nat Cell Biol; 2007 May; 9(5):573-80. PubMed ID: 17417627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage.
    Chao C; Saito S; Kang J; Anderson CW; Appella E; Xu Y
    EMBO J; 2000 Sep; 19(18):4967-75. PubMed ID: 10990460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 deficiency and misexpression of protein kinase CK2alpha collaborate in the development of thymic lymphomas in mice.
    Landesman-Bollag E; Channavajhala PL; Cardiff RD; Seldin DC
    Oncogene; 1998 Jun; 16(23):2965-74. PubMed ID: 9662328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust p53 Stabilization Is Dispensable for Its Activation and Tumor Suppressor Function.
    Kon N; Churchill M; Li H; Mukherjee S; Manfredi JJ; Gu W
    Cancer Res; 2021 Feb; 81(4):935-944. PubMed ID: 33323382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcriptional regulatory function of p53 is essential for suppression of mouse skin carcinogenesis and can be dissociated from effects on TGF-beta-mediated growth regulation.
    Ponnamperuma RM; King KE; Elsir T; Glick AB; Wahl GM; Nister M; Weinberg WC
    J Pathol; 2009 Oct; 219(2):263-74. PubMed ID: 19718706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No requirement for V(D)J recombination in p53-deficient thymic lymphoma.
    Liao MJ; Zhang XX; Hill R; Gao J; Qumsiyeh MB; Nichols W; Van Dyke T
    Mol Cell Biol; 1998 Jun; 18(6):3495-501. PubMed ID: 9584189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promyelocytic leukemia protein is required for gain of function by mutant p53.
    Haupt S; di Agostino S; Mizrahi I; Alsheich-Bartok O; Voorhoeve M; Damalas A; Blandino G; Haupt Y
    Cancer Res; 2009 Jun; 69(11):4818-26. PubMed ID: 19487292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of Irf5 protects hematopoietic stem cells from DNA damage-induced apoptosis and suppresses γ-irradiation-induced thymic lymphomagenesis.
    Bi X; Feng D; Korczeniewska J; Alper N; Hu G; Barnes BJ
    Oncogene; 2014 Jun; 33(25):3288-97. PubMed ID: 23912454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 must be competent for transcriptional regulation to suppress tumor formation.
    Nistér M; Tang M; Zhang XQ; Yin C; Beeche M; Hu X; Enblad G; van Dyke T; Wahl GM
    Oncogene; 2005 May; 24(22):3563-73. PubMed ID: 15750633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Punish or cherish: p53, metabolism and tumor suppression].
    Albagli O
    Med Sci (Paris); 2015 Oct; 31(10):869-80. PubMed ID: 26481026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unravelling mechanisms of p53-mediated tumour suppression.
    Bieging KT; Mello SS; Attardi LD
    Nat Rev Cancer; 2014 May; 14(5):359-70. PubMed ID: 24739573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Ras, Raf and L-myc but not Bcl-2 family proteins is linked with resistance to TCR-mediated apoptosis and tumorigenesis in thymic lymphomas from TCR transgenic mice.
    Kobzdej M; Matuszyk J; Strzadala L
    Leuk Res; 2000 Jan; 24(1):33-8. PubMed ID: 10634643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell type- and promoter-specific roles of Ser18 phosphorylation in regulating p53 responses.
    Chao C; Hergenhahn M; Kaeser MD; Wu Z; Saito S; Iggo R; Hollstein M; Appella E; Xu Y
    J Biol Chem; 2003 Oct; 278(42):41028-33. PubMed ID: 12909629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-catenin expression results in p53-independent DNA damage and oncogene-induced senescence in prelymphomagenic thymocytes in vivo.
    Xu M; Yu Q; Subrahmanyam R; Difilippantonio MJ; Ried T; Sen JM
    Mol Cell Biol; 2008 Mar; 28(5):1713-23. PubMed ID: 18160717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ser18 and 23 phosphorylation is required for p53-dependent apoptosis and tumor suppression.
    Chao C; Herr D; Chun J; Xu Y
    EMBO J; 2006 Jun; 25(11):2615-22. PubMed ID: 16757976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deconstructing networks of p53-mediated tumor suppression in vivo.
    Kaiser AM; Attardi LD
    Cell Death Differ; 2018 Jan; 25(1):93-103. PubMed ID: 29099489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression.
    Brady CA; Jiang D; Mello SS; Johnson TM; Jarvis LA; Kozak MM; Kenzelmann Broz D; Basak S; Park EJ; McLaughlin ME; Karnezis AN; Attardi LD
    Cell; 2011 May; 145(4):571-83. PubMed ID: 21565614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs, wild-type and mutant p53: more questions than answers.
    Jones M; Lal A
    RNA Biol; 2012 Jun; 9(6):781-91. PubMed ID: 22664917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in protein expression in p53 deleted spontaneous thymic lymphomas.
    Honoré B; Vorum H; Pedersen AE; Buus S; Claësson MH
    Exp Cell Res; 2004 Apr; 295(1):91-101. PubMed ID: 15051493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.